Write some highlights for the following article:

A lifesaving vaccine against meningitis has not yet been  introduced because the NHS has failed to agree a price. A lifesaving vaccine against meningitis B could be given to babies for just £20 a dose – but it has yet to be introduced because the NHS has failed to agree a price after nine months of negotiations. Bexsero, the first jab to protect against the leading cause of life-threatening bacterial meningitis, was recommended for all infants as part of a national immunisation programme in March 2014. The Joint Committee on Vaccination and Immunisation said approval was subject to a cost-effective price being agreed between the manufacturer and the Department of Health, with talks beginning in July 2014. The maximum price being considered under negotiations is around £20 – a significant saving compared with GlaxoSmithKline's 'list price' of £75. Children need three doses in the first year of life, making the maximum final bill for the 700,000 born each year in England and Wales £42million. GPs are also paid a £7.50 fee for each dose administered. Campaigners have warned the lack of urgency from health officials is costing lives. Meningitis B can kill a healthy child within hours of the first symptoms. Since the vaccine was licensed two years ago there have been 1,130 cases, of which at least 452 people died or suffered disabilities. Chris Head, chief executive of the Meningitis Research Foundation, said: 'These price negotiations have been ongoing since July 2014. 'Meanwhile babies and children continue to die or suffer devastating injury, with lifelong costs to the government of someone seriously disabled from the disease ranging from £3million to £4.5million.' Earlier this week Health Secretary Jeremy Hunt said he wanted to introduce the vaccine on the NHS as soon as possible but his hands will be tied by General Election 'purdah' after the middle of next week. A Department of Health spokesman said: 'We are very clear that we want to see this vaccine introduced as soon as possible to help protect children from this devastating disease – but only at a price that represents good value for money for the NHS.' Bexsero is the first jab to protect against the leading cause of life-threatening bacterial meningitis.
Lifesaving vaccine against meningitis B could be given to babies for £20.
But the NHS has failed to agree a price after nine months of negotiations.
Final bill for 700,000 born each year in England and Wales is £42million.
Skriv några höjdpunkter för följande artikel: Ett livräddande vaccin mot hjärnhinneinflammation har ännu inte införts eftersom NHS har misslyckats med att komma överens om ett pris. Ett livräddande vaccin mot hjärnhinneinflammation B skulle kunna ges till spädbarn för bara 20 pund per dos – men det har ännu inte införts eftersom NHS inte har lyckats enas om ett pris efter nio månaders förhandlingar. Bexsero, den första jabben att skydda mot den främsta orsaken till livshotande bakteriell meningit, rekommenderades för alla spädbarn som en del av ett nationellt immuniseringsprogram i mars 2014. Den gemensamma kommittén för vaccination och vaccination sade godkännande var föremål för ett kostnadseffektivt pris som överenskommits mellan tillverkaren och hälsodepartementet, med samtal som börjar i juli 2014. Det högsta pris som beaktas under förhandlingarna är cirka 20 pund – en betydande besparing jämfört med GlaxoSmithKlines "listpris" på 75 pund. Barn behöver tre doser under det första levnadsåret, vilket gör den maximala sluträkningen för de 700 000 som föds varje år i England och Wales 42 miljoner pund. GPs betalas också en £ 7,50 avgift för varje dos som administreras. Kampanjörer har varnat för att bristen på brådska från hälso- och sjukvårdspersonal kostar liv. Meningit B kan döda ett friskt barn inom några timmar efter de första symptomen. Sedan vaccinet godkändes för två år sedan har det förekommit 1 130 fall, varav minst 452 personer dog eller drabbades av funktionsnedsättning. Chris Head, chef för Meningitis Research Foundation, sade: "Dessa prisförhandlingar har pågått sedan juli 2014. "Men medan spädbarn och barn fortsätter att dö eller lida förödande skador, med livslånga kostnader för regeringen för någon allvarligt funktionshindrad från sjukdomen varierar från £ 3 miljoner till £ 4,5 miljoner." Tidigare i veckan sade hälsominister Jeremy Hunt att han ville introducera vaccinet på NHS så snart som möjligt men hans händer kommer att bindas av General Election 'purdah' efter mitten av nästa vecka. En talesman för hälsodepartementet sade: ”Vi är mycket tydliga med att vi vill att detta vaccin införs så snart som möjligt för att hjälpa till att skydda barn från denna förödande sjukdom – men bara till ett pris som ger bra valuta för pengarna för NHS.” Bexsero är den första jabben som skyddar mot den främsta orsaken till livshotande bakteriell meningit.
Write some highlights for the following article: A life-saving vaccine against meningitis has not yet been introduced because the NHS has failed to agree on a price. A life-saving vaccine against meningitis B could be given to infants for only £20 per dose – but it has not yet been introduced because the NHS has not managed to agree on a price after nine months of negotiations. Bexsero, the first jab to protect against the main cause of life-threatening bacterial meningitis, was recommended for all infants as part of a national immunisation program in March 2014. The Joint Committee on vaccination and vaccination said approval was subject to a cost-effective price agreed between the manufacturer and the Department of Health, with talks beginning in July 2014. The highest price taken into account during the negotiations is about £20 – a significant saving compared to GlaxoSmithKline's "list price" of £75. Children need three doses in the first year of life, making the maximum final count for the 700,000 born each year in England and Wales £42 million. GPs are also paid a £7.50 fee for each dose administered. Campaigners have warned that the lack of urgency from health professionals costs lives. Meningitis B can kill a healthy child within hours of the first symptoms. Since the vaccine was approved two years ago, there have been 1,130 cases, of which at least 452 people died or suffered from disability. Chris Head, head of the Meningitis Research Foundation, said: "These price negotiations have been ongoing since July 2014. "But while infants and children continue to die or suffer devastating injuries, with lifelong costs to the government for someone seriously disabled from the disease ranging from £3 million to £4.5 million." Earlier this week, Health Minister Jeremy Hunt said he wanted to introduce the vaccine on NHS as soon as possible but his hands will be tied by General Election 'purdah' after mid-next week. A spokesman for the Ministry of Health said: 'We are very clear that we want this vaccine to be introduced as soon as possible to help protect children from this devastating disease – but only at a price that provides good value for money for the NHS'. Bexsero is the first jab to protect against the main cause of life-threatening bacterial meningitis.
Livräddningsvaccin mot meningit B kunde ges till spädbarn för £20. Men NHS har misslyckats med att komma överens om ett pris efter nio månaders förhandlingar. Slutnotan för 700 000 födda varje år i England och Wales är 42 miljoner pund.
Lifesaving vaccine against meningitis B could be given to infants for £20. But the NHS has failed to agree on a prize after nine months of negotiations. The final bill for 700,000 born each year in England and Wales is £42 million.